SUPN Projected Dividend Yield
Supernus Pharmaceuticals Inc ( NASDAQ : SUPN )Supernus Pharmaceuticals, Inc. is a biopharmaceutical company. Co. is focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. Co. is also developing a range of novel CNS product candidates, including new potential treatments for hypomobility in PD, epilepsy, depression, and other CNS disorders. 21 YEAR PERFORMANCE RESULTS |
SUPN Dividend History Detail SUPN Dividend News SUPN Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |